We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+20.96%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$976M
AUM Growth
+$122M
Cap. Flow
-$88.9M
Cap. Flow %
-9.11%
Top 10 Hldgs %
19.05%
Holding
231
New
35
Increased
79
Reduced
34
Closed
30

Top Buys

Rank Stock Value
1
REVG
REV Group
REVG
+$13.5M
2
SHAK icon
Shake Shack
SHAK
+$6.72M
3
SKYW icon
Skywest
SKYW
+$6.1M
4
OSIS icon
OSI Systems
OSIS
+$5.68M
5
GRBK icon
Green Brick Partners
GRBK
+$4.91M

Top Sells

Rank Stock Value
1
SMCI icon
Super Micro Computer
SMCI
+$16.7M
2
CELH icon
Celsius Holdings
CELH
+$12.2M
3
CBAY
Cymabay Therapeutics
CBAY
+$10.3M
4
CYTK icon
Cytokinetics
CYTK
+$8.56M
5
FLNC icon
Fluence Energy
FLNC
+$7.83M

Sector Composition

Rank Sector Weight
1 Technology 26.42%
2 Industrials 19.31%
3 Healthcare 13.08%
4 Financials 9.58%
5 Consumer Discretionary 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EG icon
176
Everest Group
EG
$14.4B
– –
-8,517
Closed -$3.01M
FDX icon
177
FedEx
FDX
$75.4B
– –
-14,679
Closed -$3.71M
FLNC icon
178
Fluence Energy
FLNC
$2.44B
– –
-328,405
Closed -$7.83M
FTAI icon
179
FTAI Aviation
FTAI
$22.2B
– –
-59,402
Closed -$2.76M
IHI icon
180
iShares US Medical Devices ETF
IHI
$3.37B
– –
-74,009
Closed -$3.99M
IWO icon
181
iShares Russell 2000 Growth ETF
IWO
$15B
– –
-10,169
Closed -$2.56M
KRYS icon
182
Krystal Biotech
KRYS
$9.66B
– –
-49,073
Closed -$6.09M
MATX icon
183
Matsons
MATX
$6.18B
– –
-6,227
Closed -$682K
MRTN icon
184
Marten Transport
MRTN
$1.22B
– –
-10,787
Closed -$226K
MTN icon
185
Vail Resorts
MTN
$5.3B
– –
-2,467
Closed -$527K
OLLI icon
186
Ollie's Bargain Outlet
OLLI
$4.94B
– –
-43,384
Closed -$3.29M
PODD icon
187
Insulet
PODD
$9.79B
– –
-2,533
Closed -$550K
ROIV icon
188
Roivant Sciences
ROIV
$26.2B
– –
-158,015
Closed -$1.77M
SLG icon
189
SL Green Realty
SLG
$3.99B
– –
-95,823
Closed -$4.33M
VC icon
190
Visteon
VC
$2.78B
– –
-12,096
Closed -$1.51M
VFC icon
191
VF Corp
VFC
$5.89B
– –
-106,573
Closed -$2M
VRNA
192
DELISTED
Verona Pharma
VRNA
– –
-169,126
Closed -$3.36M
XBI icon
193
State Street SPDR S&P Biotech ETF
XBI
$10.3B
– –
-42,094
Closed -$3.76M
XMTR icon
194
Xometry
XMTR
$5.34B
– –
-82,172
Closed -$2.95M
HCP
195
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
– –
-134,498
Closed -$3.18M
CBAY
196
DELISTED
Cymabay Therapeutics
CBAY
– –
-434,507
Closed -$10.3M
KRTX
197
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-9,644
Closed -$3.05M
IMGN
198
DELISTED
Immunogen Inc
IMGN
– –
-148,672
Closed -$4.41M
4 5 6 7
8

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Nicholas Investment Partners held 231 positions worth $976M, up 14% from $855M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nicholas Investment Partners withdrew a net $88.9M in Q1 2024, closing 30 positions and reducing 34 holdings. Its most notable exit was Cymabay Therapeutics, an estimated $10.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Nicholas Investment Partners opened a new position in REV Group worth $15.9M.

  • Nicholas Investment Partners's largest Q1 2024 buy was REV Group: 720,446 shares worth $15.9M.
  • Nicholas Investment Partners added most to Kontoor Brands in Q1 2024, an estimated $3.93M increase.
  • Nicholas Investment Partners's biggest Q1 2024 reduction was Super Micro Computer, cutting an estimated $16.7M.
  • Nicholas Investment Partners fully exited Cymabay Therapeutics in Q1 2024, selling an estimated $10.3M.
  • Nicholas Investment Partners's ten largest holdings make up 19% of its $976M portfolio in Q1 2024.
  • Nicholas Investment Partners opened 35 new positions and closed 30 in Q1 2024.
  • Nicholas Investment Partners's portfolio value rose 14% quarter-over-quarter to $976M.

Based on Nicholas Investment Partners's 13F filing for Q1 2024, filed 14 May 2024.